Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Operationalizing Precision Medicine in Rare Disease Trials Aligning Trials with Patient-Lived Experiences How To Prevent Failure in Rare Disease Trials? Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development
Clinical Operations, • 9/19/25 Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials Previous How To Prevent Failure in Rare Disease Trials? Next Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials You Might Also Like What Matters to Payers: Conversations You Should Start During Phase 2 Operationalizing Precision Medicine in Rare Disease Trials Aligning Trials with Patient-Lived Experiences How To Prevent Failure in Rare Disease Trials? Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development
